Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sodium zirconium cyclosilicate, an orally administered, non-absorbed, microporous zirconium silicate, acts as a highly selective cation exchanger to remove excess potassium (K+) in vivo. It has potential use in the research of chronic kidney disease (CKD) [1] [2].
説明 | Sodium zirconium cyclosilicate, an orally administered, non-absorbed, microporous zirconium silicate, acts as a highly selective cation exchanger to remove excess potassium (K+) in vivo. It has potential use in the research of chronic kidney disease (CKD) [1] [2]. |
In vitro | Sodium zirconium cyclosilicate (ZS-9) is a crystalline, inorganic cation exchanger highly selective for trapping excess monovalent cations, particularly K+ and ammonium ions. Its exchange capacity for divalent ions such as Ca2+ and Mg2+ is less than 0.05 mEq/g, with over 25-fold greater selectivity for K+ than for Ca2+ or Mg2+ [1]. |
In vivo | Sodium zirconium cyclosilicate (ZS-9; 2-6 g/kg; p.o.; daily, for 5 days) effectively uptakes and removes potassium ions in Sprague-Dawley rats, with subsequent recovery in feces [2]. |
分子量 | 365.46 |
分子式 | Na2O9Si3Zr |
CAS No. | 17141-74-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sodium zirconium cyclosilicate 17141-74-1 Others Inhibitor inhibitor inhibit